Bad Homburg, Germany

Cornelius Jungheinrich

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Cornelius Jungheinrich: Innovator in Pharmaceutical Coupling Technologies

Introduction

Cornelius Jungheinrich, an innovative inventor based in Bad Homburg, Germany, has made significant contributions to the field of pharmaceutical technology with a total of four patents to his name. His latest inventions focus on coupling proteins and low-molecular substances to modified polysaccharides, paving the way for advancements in therapeutic applications.

Latest Patents

Jungheinrich's latest patents include two notable inventions:

1. **Coupling Proteins to a Modified Polysaccharide**: This invention relates to a method that facilitates the coupling of proteins to a starch-derived modified polysaccharide. The binding interaction is established through a covalent bond created by a coupling reaction involving the terminal aldehyde group of the modified polysaccharide and a functional group of the protein. This invention also encompasses pharmaceutical compositions that contain the conjugates formed through this process, as well as their applications in the prophylaxis or therapy of both human and animal bodies.

2. **Coupling Low-Molecular Substances to a Modified Polysaccharide**: Similar to his work with proteins, this patent details a method for coupling low-molecular weight substances to the same modified polysaccharide. The covalent bond formation follows a process akin to protein coupling. This invention also contributes to the development of pharmaceutical compositions that comprise these conjugates, which hold potential for therapeutic and prophylactic use.

Career Highlights

Cornelius Jungheinrich is a key member of Fresenius Kabi Deutschland GmbH, where he has honed his expertise in pharmaceutical innovation. His work showcases a blend of creativity and scientific rigor, cementing his status within the industry.

Collaborations

Throughout his career, Jungheinrich has collaborated with noteworthy colleagues, including Jurgen Hemberger and Michele Orlando, who have contributed to the success of their collective research efforts. These collaborations emphasize the importance of teamwork in achieving significant advancements in pharmaceutical technologies.

Conclusion

Cornelius Jungheinrich's innovative approach in coupling proteins and low-molecular substances to modified polysaccharides exemplifies the potential of new therapeutic methods in the pharmaceutical realm. His contributions underline the importance of innovation in enhancing healthcare solutions, showcasing how dedicated inventors can lead the charge in developing key technologies for the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…